11 Neurological complications of acquired cobalamin deficiency: clinical aspects

Bailliere's Clinical Haematology

Volumn 8, Issue 3, 1995, Pages 657-678

  Savage, David G ^a   Lindenbaum, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; FOLIC ACID; HEMOGLOBIN; NITRIC OXIDE;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; HUMAN; NEUROLOGIC EXAMINATION; NEUROLOGICAL COMPLICATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHILLING TEST; VITAMIN DEFICIENCY;

HUMAN; NERVOUS SYSTEM DISEASES; VITAMIN B 12 DEFICIENCY;

EID: 0029165415     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(05)80225-2     Document Type: Article

References (112)

1. Subacute Degeneration of the Brain in Pernicious Anemia
2. NEUROLOGIC ASPECTS OF PRIMARY ANEMIA
3. Diagnosis of cobalamin deficiency. I. Usefulness of serum methylamlonic acid and total homocysteine concentrations
4. 12 in megaloblastic anemia
5. Megaloblastic haemopoiesis in patients receiving nitrous oxide
6. 12 deficiency
7. Virus infections of the nervous system
8. Folic acid therapy and spinal-cord degeneration in pernicious anemia
9. 12-Behandlung unter Berücksichtigung der Folsäure
10. Megaloblastic anemia and brief exposure to nitrous oxide — a causal relationship?
11. 12 without intrinsic factor
12. The relation of therapy in pernicious anemia to changes in the nervous system
13. Myeloneuropathy and macrocytosis associated with nitrous oxide abuse
14. 12 deficiency presenting with severe pseudoathetosis of upper limbs
15. 12) deficiency
16. Megaloblastic anaemia in a vegetarian Hindu community
17. The effects of combined folic acid and liver extract therapy
18. Responses to small doses of folic acid in pernicious anemia
19. Preoperative methionine loading enhances restoration of the cobalamin-dependent enzyme methionine synthase after nitrous oxide anesthesia
20. 12
21. Clinical features of pernicious anaemia
22. The danger of folic acid in multivitamin preparations
23. Resolution of ineffective erythropoiesis of pernicious anemia and ‘strongly suggestive’ folate lack in response to folic acid
24. Deficient catecholamine release as the basis of orthostatic hypotension in pernicious anaemia
25. Pernicious anemia masked by multivitamins containing folic acid
26. 12 deficiency
27. A history of nitrous oxide
28. Lhermitte's sign in subacute combined degeneration of the cord
29. THE OCCURRENCE AND TREATMENT OF NEUROLOGIC CHANGES IN PERNICIOUS ANEMIA
30. Subacute combined degeneration and pernicious anaemia
31. The peripheral nerves in cases of subacute combined degeneration of the cord
32. Nitrous oxide-induced myeloneuropathy: report of cases
33. Nitrous oxide-induced myelopathy-neuropathy: potential for chronic misuse by dentists
34. 12 und Folsäure
35. SENSORY CHANGES IN THE SUBACUTE COMBINED DEGENERATION OF PERNICIOUS ANEMIA
36. 12 in megaloblastic anemias
37. Neurologic aspects of cobalamin deficiency
38. 12 deficiency?
39. THE ROLE OF CONJUGATED AND FREE FORMS OF FOLIC ACID IN THE CONTROL OF PERNICIOUS ANEMIA: I. CLINICAL OBSERVATIONS
40. Current concepts in therapy: megaloblastic anemia
41. Current concepts in therapy: megaloblastic anemia
42. Nitrous oxide: Clinical and electrophysiologic investigation of neurologic complications
43. 12 deficiency
44. 12 deficiency
45. SUBACUTE COMBINED DEGENERATION OF THE SPINAL CORD IN PERNICIOUS ANEMIA
46. The course of subacute combined degeneration of the spinal cord
47. Folic acid therapy: Its effect as observed in two patients with pernicious anemia and neurologic symptoms
48. 12 deficiency in Indian infants. A clinical syndrome
49. Subacute combined degeneration of the cord and achlorhydric peripheral neuropathies without anaemia
50. 12 deficiency
51. 12 deficiency and subacute combined degeneration of the spinal cord (funicular spinal disease)
52. NERVOUS AND MENTAL MANIFESTATIONS OF PRE-PERNICIOUS ANEMIA.
53. Treatment of tetanus: severe bone marrow depression after prolonged nitrous oxide anaesthesia
54. Myeloneuropathy after prolonged exposure to nitrous oxide
55. Zur Kermtoriss der perniciösen Anämie
56. Subacute combined degeneration
57. Clinical spectrum of folate deficiency
58. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis
59. Diagnosis of cobalamin deficiency II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations
60. Neuropsychiatric disorders in cobalamin deficiency
61. Cobalamin and unsaturated transcobalamin values in pernicious anaemia: relation to treatment
62. Responses to ‘physiologic’ doses of folic acid in the megaloblastic anemias
63. Multiple sclerosis and other demyelinating diseases: clinical features
64. A review of nervous and mental aspects of pernicious anaemia
65. 12 deficiency
66. Neuropathy after nitrous oxide abuse
67. 12 deficiency
68. The Neurology of Gastrointestinal Disease
69. The myelopathy of pernicious anemia. A neuropathological reappraisal
70. Myelopathies affecting anterior horn cells
71. ‘Recreational’ misuse of nitrous oxide
72. 12 and folic acid in pernicious anemia
73. Subacute combined degeneration of the spinal cord in non-Addisonian megaloblastic anaemia
74. 12
75. 12 deficiency after treatment with folic acid in tropical sprue
76. Prognosis in the neurologic manifestations of pernicious anemia.
77. SUBACUTE COMBINED DEGENERATION OF THE SPINAL CORD
78. 2O cartridges through a whipped-cream dispenser
79. Folate-cobalamin interactions
80. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies
81. 12 deficiency is the primary cause of megaloblastic anaemia in Zimbabwe
82. 12-deficient subjects?
83. 12 og folic acid i små doser per os ved pernicios anemi
84. The effect of "minute" and "titrated" amounts of folic acid on the megaloblastic anemia of tropical sprue.
85. Subacute myeloneuropathy after abuse of nitrous oxide: an electron microscopic study on the peripheral nerve
86. The neuropsychiatry of megaloblastic anaemia
87. Nervous symptoms in pernicious anemia
88. Studies on the haemopoietic toxicity of nitrous oxide in man
89. Megaloblastic Madness
90. Clinical spectrum and diagnosis of cobalamin deficiency
91. Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency
92. Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy
93. Subacute toxic delirium following nitrous oxide abuse
94. 12 with normal blood and marrow
95. Diagnostic value of small oral doses of folic acid in megaloblastic anaemia
96. Subacute combined degeneration of the spinal cord: MR findings
97. Magnetic resonance imaging in cobalamin deficiency
98. 12
99. Polyneuropathy due to nutritional deficiency and alcoholism
100. Subacute combined degeneration of the spinal cord
101. 12, folic acid and ascorbic acid in the megaloblastic anemias
102. The electroencephalogram in pernicious anemia
103. The electroencephalogram in pernicious anaemia and subacute combined degeneration of the cord
104. Pernicious anemia seen initially as orthostatic hypotension
105. 12 deficiency
106. 12 in pernicious anemia. Studies on patients treated with these substances over a ten-year period
107. THE NERVOUS SYMPTOMS IN PERNICIOUS ANEMIA
108. The mental changes associated with pernicious anemia
109. Treatment of neurologic changes complicating pernicious anemia
110. 12 deficiency and psychiatric disorders: case report and literature review